Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
BPC-157 and TB-500 are investigational peptides studied in areas related to cellular repair and tissue-response mechanisms. Preclinical research on BPC-157 has explored tendon, ligament, muscle, and gastrointestinal tissue models, while TB-500 is a seven-amino-acid fragment related to thymosin beta-4 that has been investigated for its potential role in cellular migration and repair pathways.
Current evidence remains predominantly preclinical. The FDA reports insufficient human safety and effectiveness data for BPC-157 and has identified no clinical studies or human exposure data for TB-500 through the routes it evaluated. The safety and effectiveness of the BPC-157 + TB-500 combination have not been established in humans.
For laboratory research use only. Not for human consumption.
BPC-157 and TB-500 are investigational peptides studied in areas related to cellular repair and tissue-response mechanisms. Preclinical research on BPC-157 has explored tendon, ligament, muscle, and gastrointestinal tissue models, while TB-500 is a seven-amino-acid fragment related to thymosin beta-4 that has been investigated for its potential role in cellular migration and repair pathways.
Current evidence remains predominantly preclinical. The FDA reports insufficient human safety and effectiveness data for BPC-157 and has identified no clinical studies or human exposure data for TB-500 through the routes it evaluated. The safety and effectiveness of the BPC-157 + TB-500 combination have not been established in humans.
For laboratory research use only. Not for human consumption.